U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H14N4O2
Molecular Weight 198.2224
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TEMGICOLURIL

SMILES

[H][C@@]12N(C)C(=O)N(C)[C@]1([H])N(C)C(=O)N2C

InChI

InChIKey=XIUUSFJTJXFNGH-OLQVQODUSA-N
InChI=1S/C8H14N4O2/c1-9-5-6(11(3)7(9)13)12(4)8(14)10(5)2/h5-6H,1-4H3/t5-,6+

HIDE SMILES / InChI

Molecular Formula C8H14N4O2
Molecular Weight 198.2224
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/598490 | https://www.ncbi.nlm.nih.gov/pubmed/3979535

Tetramethylglycoluril (MEBICAR, Adaptol, Mebicarum) is an anxiolytic similar to organism natural metabolites with nootropic and stress-protective characteristics. Tetramethylglycoluril belongs to a group of non-benzodizepam tranquilizers. It works by effecting on the structure of limbic-reticular activity and 4 main neuromediator systems – γ aminobutyric acid, choline -, serotonin- and adrenergic. Tetramethylglycoluril increases serotonin levels, decreases noradrenaline level with no effect on dopamine and no anticholinergic activity. It acts on hypothalamus emotional zone, thus providing moderate tranquilizing effect. Tetramethylglycoluril improves oxygen consumption by myocardium, normalizes blood electrolyte balance, stimulates protein synthesis and increases cell's energy resource. Tetramethylglycoluril is used to treat neurotic disorders (anxiety, awareness, fear, emotional density, irritability) caused by exhausting psycho-emotional, nervous and physical loads. Mebicar relieves or completely removes nicotine abstinence.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Adaptol

Approved Use

Unknown
Primary
Adaptol

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Clinical pharmacokinetics of mebikar].
1984 May-Jun
Patents

Patents

Sample Use Guides

500 mg 2-3 times a day. The maximum single dose is 3 g, the daily - 10 g. The duration of the course of treatment is from several days to 2-3 months. In complex therapy as a means of reducing the craving for tobacco smoking - 500-1000 mg 3 times a day for 5-6 weeks.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:42:14 GMT 2023
Edited
by admin
on Fri Dec 15 19:42:14 GMT 2023
Record UNII
55FE6NPG89
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TEMGICOLURIL
INN  
Official Name English
TETRAMETHYLGLYCOLURIL
Common Name English
Temgicoluril [WHO-DD]
Common Name English
temgicoluril [INN]
Common Name English
GLYCOLURIL, 1,3,4,6-TETRAMETHYL-
Common Name English
MEBIKAR
Common Name English
MEBICAR
WHO-DD  
Common Name English
IMIDAZO(4,5-D)IMIDAZOLE-2,5(1H,3H)-DIONE, TETRAHYDRO-1,3,4,6-TETRAMETHYL-, CIS-
Systematic Name English
ADAPTOL
Common Name English
Classification Tree Code System Code
WHO-VATC QN06BX21
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
WHO-ATC N06BX21
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL3707390
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
PUBCHEM
122282
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
INN
11515
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY INN
CAS
106780-29-4
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
ALTERNATIVE
EPA CompTox
DTXSID60143588
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
EVMPD
SUB31717
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
FDA UNII
55FE6NPG89
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
DRUG BANK
DB13522
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
CAS
10095-06-4
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
SMS_ID
100000124183
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
WIKIPEDIA
ADAPTOL
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
MESH
C015979
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
DRUG CENTRAL
4861
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
NCI_THESAURUS
C179125
Created by admin on Fri Dec 15 19:42:14 GMT 2023 , Edited by admin on Fri Dec 15 19:42:14 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY